Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2001; 126(51/52): 1472-1475
DOI: 10.1055/s-2001-19207
DOI: 10.1055/s-2001-19207
CME
© Georg Thieme Verlag Stuttgart · New York
Vorhofflimmern - Therapie
Atrial fibrillation - TreatmentFurther Information
Publication History
Publication Date:
20 December 2001 (online)
Die Behandlung von Vorhofflimmern beinhaltet im Wesentlichen drei Aspekte: die Prävention thromboembolischer Ereignisse, die Frequenzlimitierung sowie die Wiederherstellung und Erhaltung eines Sinusrhythmus.
Literatur
- 1 Arentz T, Blum J, von Rosenthal J, Peters K, Kalusche D. Fokales paroxysmales Vorhofflimmern. Erste Erfahrungen mit der Behandlung mit Hochfrequenz-Katheterablation. Dtsch med Wochenschr. 2000; 125 479-483
- 2 Coplen S E, Antman E M, Berlin J A. et al . Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. Circulation. 1990; 82 1106-1116
- 3 Danias P G, Caulfield T A, Weigner M J, Silverman D J, Manning W J. Likelihood of spontaneous conversion of atrial fibrillation to sinus rhythm. J Am Coll Cardiol. 1998; 31 588-592
- 4 European Atrial Fibrillation Trial Study Group . Secondary prevention in non-rheumatic atrial fibrillation after transient ischemic attack or minor stroke. Lancet. 1993; 342 1255-1262
- 5 Ewy G A. Optimal technique for electrical cardioversion of atrial fibrillation. Circulation. 1992; 86 1645-1647
- 6 Ezekowitz M D, Bridgers S L, James K E. et al . Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med. 1992; 327 1406-1412
- 7 Fuster V, Rydén L E, Asinger R W. et al . ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. Eur Heart J. 2001; 22 1852-1923
- 8 Golzari H, Cebul R D, Bahler R C. Atrial fibrillation: restoration and maintenance of sinus rhythm and indications for anticoagulation therapy. Ann Intern Med. 1996; 125 311-323
- 9 Hemmer W, Starck C, Botha C. et al . Initial experience with a modified left atrial maze procedure concomitant to cardiac surgery. Herzschr Elektrophys. 2000; 11 235-243
- 10 Hohnloser S H, Kuck K H, Lilienthal J. Rhythm or rate control in atrial fibrillation. Lancet. 2000; 356 1789-1794
- 11 Kannel W B, Abbott R D, Savage D D, McNamara P M. Epidemiologic features of chronic atrial fibrillation. N Engl J Med. 1982; 306 1018-1022
- 12 Klein A L, Grimm R A, Murray R D. et al . Use of transesophageal echocardiography to guide cardoversion in patients with atrial fibrillation. N Engl J Med. 2001; 344 1411-1420
- 13 Ozcan C, Jahangir A, Friedman P A. et al . Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. N Engl J Med. 2001; 344 1043-1050
- 14 Petersen P, Boysen G, Godtfredsen J. et al . Plazebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. Lancet. 1989; 1 175-179
- 15 Reisinger J, Gatterer E, Heinze G. et al . Prospective comparison of flecainide versus sotalol for immediate cardioversion of atrial fibrillation. Am J Cardiol. 1998; 81 1450-1454
- 16 Roy D, Talajic M, Dorian P. et al . Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med. 2000; 342 913-920
- 17 Schumacher B, Jung W, Lewalter T, Vahlhaus C, Wolpert C, Lüderitz B. Radiofrequency ablation of atrial flutter due to administration of class IC antiarrhythmic drugs for atrial fibrillation. Am J Cardiol. 1999; 83 710-713
- 18 Shah D, Haissaguerre M, Jais P. et al . Curative catheter ablation of paroxysmal atrial fibrillation in 200 patients. PACE. 2001; 24 1541-1558
- 19 Stroke Prevention in Atrial Fibrillation Investigators . Stroke Prevention in Atrial Fibrillation Study; final results. Circulation. 1991; 84 527-539
- 20 Stroke Prevention in Atrial Fibrillation Investigators . Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation study. Stroke Prevention in Atrial Fibrillation II Study. Lancet. 1994; 343 687-691
- 21 The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators . The effect of low-dose warfarin on the risk of stroke in patients with non- rheumatic atrial fibrillation. N Engl J Med. 1990; 323 1505-1511
- 22 The NHLNI AFFIRM Investigators . Atrial fibrillation follow-up investigation of rhythm management. Am J Cardiol. 1997; 79 1198-1202
- 23 Van Gelder I C, Crijns H J, Tieleman R G. et al . Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation. Arch Intern Med. 1996; 156 2585-2592
Korrespondenz
Priv.-Doz. Dr. med. Jens Jung
Medizinische Universitätsklinik und Poliklinik, Innere
Medizin III (Kardiologie/Angiologie), Universitätskliniken
des Saarlandes
66421 Homburg/Saar
Phone: 06841/1623359
Fax: 06841/1623394
Email: jung@med-in.uni-saarland.de